Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02393794
Title Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Priyanka Sharma
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Kansas Cancer Center - Clinical Research Center Fairway Kansas 66205 United States Details
University of Kansas Cancer Center - West Kansas City Kansas 66112 United States Details
University of Kansas Cancer Center - Overland Park Overland Park Kansas 66210 United States Details
University of Kansas Cancer Center - Westwood Westwood Kansas 66205 United States Details
University of Kansas Cancer Center - South Kansas City Missouri 64131 United States Details
University of Kansas Cancer Center - North Kansas City Missouri 64154 United States Details
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field